5.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits
Lakeside Advisors, INC.'s Achieve Life Sciences Inc(ACHV) Holding History - GuruFocus
[ARS] ACHIEVE LIFE SCIENCES, INC. SEC Filing - Stock Titan
Achieve Life Sciences (NASDAQ: ACHV) plans vote to double share authorization - Stock Titan
ACHV News | ACHIEVE LIFE SCIENCES INC (NASDAQ:ACHV) - ChartMill
ACHV Stock Chart | ACHIEVE LIFE SCIENCES INC (NASDAQ:ACHV) - ChartMill
Achieve Life Sciences (ACHV) director awarded 47,250 options at $5.24 strike - Stock Titan
Achieve Life (ACHV) director receives 47,250 options at $5.24 strike - Stock Titan
ACHIEVE Life Sciences (ACHV) director reports no beneficial ownership on Form 3 - Stock Titan
Achieve Life Sciences (ACHV) director Farrow files Form 3 with no share ownership - Stock Titan
Achieve Life Sciences, Inc. Announces Board Appointments - marketscreener.com
Achieve Life Sciences appoints two new directors to board and committees - Investing.com Nigeria
Achieve Life Sciences, Inc. Files Form 8-K Current Report with SEC on May 29, 2026 - Minichart
Achieve Life Sciences appoints two new directors to board and committees By Investing.com - Investing.com South Africa
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors - The Globe and Mail
[8-K] ACHIEVE LIFE SCIENCES, INC. Reports Material Event - Stock Titan
ACHV Technical Analysis | Trend, Signals & Chart Patterns | ACHIEVE LIFE SCIENCES INC (NASDAQ:ACHV) - ChartMill
Achieve Life Sciences (ACHV) asks shareholders to double authorized common shares to 300M - Stock Titan
Achieve Life Sciences 4Q Loss/Shr 28c >ACHV - Moomoo
Achieve Life Sciences Completes Tech Transfer to Adare Pharma Solutions - Contract Pharma
[EFFECT] ACHIEVE LIFE SCIENCES, INC. SEC Filing - Stock Titan
Achieve Life Sciences Q1 2026 Earnings: Narrower-than-Expected Loss Drives OptimismEnergy Earnings Report - thelegaladvocate.com
Canaccord reiterates Achieve Life Sciences stock rating on safety data By Investing.com - Investing.com South Africa
Achieve Life Sciences (ACHV) price target decreased by 14.04% to 12.82 - MSN
Canaccord reiterates Achieve Life Sciences stock rating on safety data - Investing.com
Q3 2025 Achieve Life Sciences Inc Earnings Call Transcript - GuruFocus
Achieve Life Sciences presents long-term cytisinicline data By Investing.com - Investing.com Australia
Achieve Life Sciences presents long-term cytisinicline data - Investing.com UK
Achieve Life Sciences, Inc.: cytisinicline data indicate well-tolerated safety over 52 weeks for adults quitting smoking - Traders Union
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment - The Manila Times
Achieve Life Sciences Presents Long-Term Safety Data for Cytisinicline in Smoking Cessation at ATS 2026 - Quiver Quantitative
Achieve Life Sciences Q1 earnings call highlights - MSN
Achieve (ACHV) Q1 2026 Earnings Transcript - AOL.com
Q2 Earnings Forecast for ACHV Issued By Zacks Research - MarketBeat
Earnings call transcript: Achieve Life Sciences beats Q1 2026 EPS expectations - Investing.com Nigeria
Canaccord Genuity initiates coverage of Achieve Life Sciences (ACHV) with buy recommendation - MSN
HC Wainwright Has Optimistic Outlook of ACHV Q2 Earnings - MarketBeat
[Form 3] ACHIEVE LIFE SCIENCES, INC. Initial Statement of Beneficial Ownership - Stock Titan
Director at ACHIEVE Life Sciences (ACHV) granted 47,250 stock options at $5.59 - Stock Titan
Achieve Life Sciences: 'Hold' On Expected CRL Cytisinicline And Q4 2026 NDA Resubmission - Seeking Alpha
Achieve Life Sciences, Inc.Common Shares (NQ: ACHV - FinancialContent
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):